| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.029 | 0.3 |